NCT03009474View on ClinicalTrials.gov

Pharmacokinetics Study of CJ-30060 After Single Dose Administration in Health Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions
HypertensionHyperlipidemias
Interventions
DRUG

CJ-30060

Fixed-dose combination drug containing Amlodipine 5 mg and Valsartan 160 mg and Rosuvastatin 10 mg

DRUG

Exforge tab 5/160mg, Crestor tab 10mg

Co-administration of Amlodipine 5 mg/ Valsartan 160 mg(combination drug) and Rosuvastatin 10 mg

Trial Locations (1)

Unknown

Korea University Anam Hospital, Seoul

Sponsors
All Listed Sponsors
lead

HK inno.N Corporation

INDUSTRY